Synthesis and in vitro cytotoxicity of 1-azaanthraquinone-3-carboxamides

Archives of Pharmacal Research

Volumn 22, Issue 4, 1999, Pages 380-383

  Lee, Heesoon ^a   Lee, Chang Wook ^a   Yang, Sung Il ^b  

^a Chungbuk National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Acridine 4 carboxamide; Azaanthraquinone; Chemotherapy; Cytotoxic activity; Doxorubicin; Drug resistance

Indexed keywords

AMIDE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN;

ARTICLE; CELL COUNT; CELL CULTURE; HUMAN; SYNTHESIS;

AMIDES; ANTHRAQUINONES; ANTIBIOTICS, ANTINEOPLASTIC; CELL COUNT; DOXORUBICIN; HUMANS; TUMOR CELLS, CULTURED;

EID: 0033176221     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02979061     Document Type: Article

References (12)

1. Atwell, G. J., Rewcastle, G. W., Baguley, B. C., Denny, W. A., Potential Antitumor Agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem., 30, 664-669 (1987).
2. Baguley, B. C., Zhuang, L., Marshall, E. M., Experimental solid tumor activity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. Cancer Chemother. Pharmacol., 36, 244-248 (1995).
3. Bonner, J. A., Kozelsky, T. F., The significance of the sequence of administration of topotecan and etoposide. Cancer Chemother. Pharmacol. 39, 109-12 (1996).
4. Cortes F., Pinero J., Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells. Cancer Chemother. Pharmacol., 34, 411-5 (1994).
5. Ishida, T., Nishio, K., Arioka, H., Kurokawa, H., Fukumoto, H., Fukuoka, K., Nomoto, T., Yokote, H., Saijo, N. TAS-103, a novel dual inhibitor of DNA topoisomerase I and II. Proc. Am. Assoc. Cancer Res. 37, 428 (abstr. 2922) (1996).
6. Lee, H., Hong, S-. S. and Kim, Y-. H., Synthesis and In Vitro Evaluation of 3-Substituted-1-azaanthraquinones. Bio. Med. Chem. Lett., 6, 933-936 (1996).
7. Lee, H., Hong, S-. S., Choi, J-. Y., Cho, J. and Kim, Y-. H., Synthesis and In vitro Evaluation of 4-Substituted-1-azaanthraquinones. Arch. Pharm. Res., 21, 73-75 (1998).
8. Lee, H., Choi, J-.Y., Lee, S. I., Hong, S-.S., Cho, J. and Kim, Y-. H., Synthesis and In vitro Cytotoxicity of 3- or 4-Dialkylaminomethyl-1-Azaanthraquinones.Arch. Pharm. Res., 21, 749-752 (1998).
9. Lee, H., Lee, S. I., Yang, S. I., Synthesis and In Vitro Cytotoxicity of 3-Substituted-1,8-diazaanthraquinones Produced by Regioselective Hetero Diels-Alder Reaction. Bio. Med. Chem. Lett., 8, 2991-2994 (1998).
10. Luzzio, M. J., Besterman, J. M., Emerson, D. L., Evans, M. G., Lackey, K., Leitner P. L., Mcintyre, G., Morton B., Myers P. L., Peel M., Sisco J. M., Sternbach, D. D., Tong, W. Q., Truesdale, A., Uehling, D. E., Vuong, A., Yates, J. Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I. J. Med. Chem., 38, 395-401 (1995).
11. Skehan, P., Storeng, R., Scudiero, D, Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).
12. Utsugi, T., Aoyagi, K., Furune, Y., Sano, M., Wierzba, K., Okazaki, S., Asao, T., Yamada, Y. Antitumor acti-vity of TAS-103, a novel topoisomerase I and II inhibitor. Proc. Am. Assoc. Cancer Res. 37, 427 (abstr. 2815) (1996).